- Preview Available
- Scholarly Journal
Real-world data of dacomitinib as first-line treatment for patients with EGFR-mutant non-small-cell lung cancer
Scientific Reports (Nature Publisher Group); London Vol. 15, Iss. 1, (2025): 4593.
DOI:10.1038/s41598-024-81704-4
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.